Immune inflammatory response mediators like proteolytic enzymes and pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-12, and NO) have recently become a target of glaucoma research [15,29,30,31,32,33,34,35,36,37,38,39,40]. The gene discussed is IL1B; the disease is glaucoma.